Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Chemocentryx Inc (CCXI)

$8.75 0.00 (0.00%)

15:59 EST CCXI Stock Quote Delayed 15 Minutes

Volume:

Previous Close $8.75

Market Cap 430.06M

PE Ratio 30.17

EPS 0.29

Volume (Avg. Vol.)

Day's Range 8.75 - 8.75

52-Week Range 6.16 - 14.98

Dividend & Yield N/A (N/A)

CCXI Stock Predictions, Articles, and Chemocentryx Inc News

From InvestorPlace
From the Web

4 Top-Ranked Nasdaq Stocks That Have Doubled This Year

By Zacks Investment Research Jun 14, 2018

Investors continued to pour money into the fast-growing companies, doubling the share price of many stocks in the Nasdaq Composite Index. Compare Brokers....

5 Small-Cap ETFs and Stocks Crushing the Russell 2000

By Zacks Investment Research May 21, 2018

We have presented five ETFs & stocks that have easily crushed the Russell 2000 index this year and are likely to continue their strong performance. Compare....

ChemoCentryx Breaks Above 200-Day Moving Average - Bullish for CCXI

From Market News Video Nov 5, 2019

In trading on Tuesday, shares of ChemoCentryx, Inc. (CCXI) crossed above their 200 day moving average of $9.73, changing hands as high as $10.07 per share..

The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment

From Benzinga Nov 5, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 4) Agile Therapeutics Inc (...

ChemoCentryx Inc (CCXI) Q3 2019 Earnings Call Transcript

From The Motley Fool Nov 5, 2019

CCXI earnings call for the period ending September 30, 2019.

ChemoCentryx (CCXI) Reports Q3 Loss, Tops Revenue Estimates

From Zacks Investment Research Nov 4, 2019

ChemoCentryx (CCXI) delivered earnings and revenue surprises of 21.43% and 35.07%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

ChemoCentryx, Inc. EPS beats by $0.06, beats on revenue

From Seeking Alpha Nov 4, 2019

ChemoCentryx, Inc. (NASDAQ:CCXI): Q3 GAAP EPS of -$0.22 beats by $0.06.Revenue of $10.58M (+17.8% Y/Y) beats by $2.88M.Press Release

Notable Thursday Option Activity: ISRG, CCXI, SFM

From Market News Video Oct 31, 2019

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Intuitive Surgical Inc (ISRG), where a total volume of 4,198 contracts has been traded thus far today, a contract volume which is representative of approximately 419,800 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 69.1% of ISRG's average daily trading volume over the past month, of 607,365 shares..

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!